BZT has a lot of different anti-myeloma effects including disruption of cell cycle, induction of apoptosis, alteration of the bone marrow microenvironment, and inhibition of nuclear factor kappa B (NFκB) [15]. The gene discussed is NFKB1; the disease is plasma cell myeloma.